A GAME CHANGING ENERGY TECHNOLOGY
NEXT GENERATION
SEAWATER BATTERY
The energy crisis and environmental pollution have become increasingly serious, threatening the survival and development of mankind, the development of renewable energy, the road to sustainable development has become the focus of global industry, academia and research. Seawater batteries, a new type of environmentally friendly energy source that is inexhaustible, are emerging. The aim of this joint project between UNSW and Tiger Pharma is to develop new seawater batteries for wearable devices and household appliances with the aim of realising and promoting the widespread use of seawater batteries in new energy applications.
Current Challenges
The emergence of social issues such as China's ageing population and the expansion of the chronic disease population has provided rigid demand and room for expansion in the application of smart wearable devices in China. Sullivan predicts that the market size of China's smart wearable device industry will reach RMB 91.37 billion by 2023 as the industry's application in various verticals deepens.
The project proposes to develop a high-performance, environmentally friendly, low-cost, foldable seawater battery as an energy supply device for wearable devices. The team has developed a miniature seawater battery with energy density up to 1000W/L and good battery stability with no loss of continuous operation for over 100 hours.
Application Prospects In The Medical Market
In the implantable medical device market where electricity is the driving source, flexible batteries are more replaceable for traditional batteries. In implantable pacemakers, implantable neurostimulators, implantable electromechanical cardiac circulation systems, implantable cochlear implants, etc., the characteristics of flexible batteries make it easier to match devices that adapt to the structural requirements of the human body.
According to statistics, the active implantable medical device market size was US$18.42 billion in 2017 and is expected to grow at a CAGR of 7.8% during 2017-2022, reaching US$26.75 billion by 2022. Once the flexible battery technology matures, it will then occupy a large share of the active implantable medical device market as an important medical device consumable.
Get in Touch
We're always looking for new and exciting opportunities. Let's connect.
Remember our website：
Email：